Activation of CD8 T Cells Predicts Progression of HIV Infection in Women Coinfected with Hepatitis C Virus
Open Access
- 15 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (6) , 823-834
- https://doi.org/10.1086/650997
Abstract
Background. Because activation of T cells is associated with human immunodeficiency virus (HIV) pathogenesis, CD4 and CD8 activation levels in patienKeywords
This publication has 50 references indexed in Scilit:
- Evaluating the Impact of Hepatitis C Virus (HCV) on Highly Active Antiretroviral Therapy–Mediated Immune Responses in HCV/HIV‐Coinfected Women: Role of HCV on Expression of Primed/Memory T CellsThe Journal of Infectious Diseases, 2006
- Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.The Journal of Infectious Diseases, 2003
- T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral TherapyThe Journal of Infectious Diseases, 2003
- Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.Archives of internal medicine (1960), 2002
- Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjectsAIDS, 2002
- Hepatitis C and Progression of HIV DiseaseJAMA, 2002
- Effector and memory T-cell differentiation: implications for vaccine developmentNature Reviews Immunology, 2002
- Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐AnalysisClinical Infectious Diseases, 2001
- Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in HemophiliacsThe Journal of Infectious Diseases, 2001
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyThe Lancet, 2000